Please login to the form below

Not currently logged in
Email:
Password:

Chameleon launches Central London office

The agency’s European president Stephen Marchant will head up the new location

Chameleon Gary HobbsGlobal medical communications agency Chameleon Communications has expanded its UK operations with a Central London location after it saw another year of business growth.

Further adding to the agency's presence in Los Angeles, New York, Manchester and West London, the new venture will be lead by Chameleon's president for Europe Stephen Marchant.

Chameleon's Central London office will provide the agency's full range of medical education and digital services, including pre-launch strategic communications and publication planning.

Gary Hobbs (pictured), the Chameleon group's chief executive officer, said: “We are delighted at the consistent growth of Chameleon which has driven the opening of our latest office in Central London.

“Our 20% annual growth rate over recent years has been driven by exciting new assignments from clients such as Boehringer Ingelheim, Sanofi, Teva and Alcon and is a great reflection of the innovation and leading strategic tactical services provided by our 150 committed team members.”

Article by
Rebecca Clifford

30th August 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics